Index60可识别2小时血糖正常的自身抗体阳性人群中具有明显3期进展风险的个体:对当前1型糖尿病分期标准的启示
本研究分析3058例2小时血糖<140 mg/dL且Index60<1.00的TrialNet Pathway to Prevention参与者,发现Index60最高四分位组(不论是否合并2小时血糖最高四分位)较其他组更年轻、胰岛自身抗体阳性数目更多、C肽更低,且3期累积发病率更高(均P<0.001)。结论认为Index60可识别被2小时血糖分期标准遗漏的高进展风险个体。
要点
- 在2小时血糖<140 mg/dL的自身抗体阳性人群中,Index60最高四分位者3期累积发病率显著高于仅2小时血糖最高四分位者(P<0.001)。
- Index60最高四分位者更年轻、胰岛自身抗体阳性数目更多、C肽水平更低(均P<0.001)。
- Index60高于中位数者较低于中位数者更年轻、≥2种自身抗体阳性频率更高、HLA DR3-DQ2/DR4-DQ8频率更高、C肽AUC更低(均P<0.001)。
核心结论
- Index60可识别具有1型糖尿病特征且3期进展风险明显、但被2小时血糖分期标准遗漏的个体。
研究设计与样本
- 分析3058例Type 1 Diabetes TrialNet Pathway to Prevention参与者,基线口服葡萄糖耐量试验2小时血糖<140 mg/dL且Index60<1.00。
- 按2小时血糖和Index60最高四分位分为四组:仅2小时血糖最高四分位组(HI-2HGLU)、仅Index60最高四分位组(HI-IND60)、两者均最高四分位组(HI-BOTH)、两者均非最高四分位组(LO-BOTH)。
- 另在2小时血糖<140 mg/dL分布内和Index60<1.00分布内,分别按中位数分组比较。
主要发现
- HI-IND60和HI-BOTH组较HI-2HGLU或LO-BOTH组更年轻、>2种自身抗体阳性频率更高、C肽水平更低(均P<0.001)。
- HI-IND60和HI-BOTH组3期累积发病率高于HI-2HGLU或LO-BOTH组(均P<0.001)。
- Index60高于中位数者较低于中位数者更年轻、≥2种自身抗体阳性频率更高(P<0.001)、DR3-DQ2/DR4-DQ8频率更高(P<0.001)、C肽AUC更低(P<0.001)。
- 2小时血糖高于中位数者较低于中位数者C肽AUC更高(P<0.001),其余特征无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed whether Index60, a composite measure of fasting C-peptide, 60-min C-peptide, and 60-min glucose, could improve the metabolic staging of type 1 diabetes for progression to clinical disease (stage 3) among autoantibody-positive (Ab+) individuals with normal 2-h glucose values (<140 mg/dL). RESEARCH DESIGN AND METHODS: We analyzed 3,058 Type 1 Diabetes TrialNet Pathway to Prevention participants with 2-h glucose <140 mg/dL and Index60 <1.00 values from baseline oral glucose tolerance tests. Characteristics associated with type 1 diabetes (younger age, greater Ab+, higher HLA DR3-DQ2/DR4-DQ8 prevalence, and lower C-peptide) were compared among four mutually exclusive groups: top 2-h glucose quartile only (HI-2HGLU), top Index60 quartile only (HI-IND60), both top quartiles (HI-BOTH), and neither top quartile (LO-BOTH). Additionally, within the 2-h glucose distribution of <140 mg/dL and separately within the Index60 <1.00 distribution, comparisons were made between those above or below the medians. RESULTS: HI-IND60 and HI-BOTH were younger, with greater frequency of more than two Ab+, and lower C-peptide levels, than either HI-2HGLU or LO-BOTH (all P < 0.001). The cumulative incidence for stage 3 was greater for HI-IND60 and HI-BOTH than for either HI-2HGLU or LO-BOTH (all P < 0.001). Those with Index60 values above the median were younger and had higher frequency of two or more Ab+ (P < 0.001) and DR3-DQ2/DR4-DQ8 prevalence (P < 0.001) and lower area under the curve (AUC) C-peptide levels (P < 0.001) than those below. Those above the 2-h glucose median had higher AUC C-peptide levels (P < 0.001), but otherwise did not differ from those below. CONCLUSIONS: Index60 identifies individuals with characteristics of type 1 diabetes at appreciable risk for progression who would otherwise be missed by 2-h glucose staging criteria.
引用
- Nathan BM, Redondo MJ, Ismail H, et al. Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes. Diabetes Care. 2022. PMID: 34853027. doi:10.2337/dc21-0944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。